Full Text View
Tabular View
No Study Results Posted
Related Studies
TH9507 in Patients With HIV-Associated Lipodystrophy
This study is ongoing, but not recruiting participants.
Study NCT00435136   Information provided by Theratechnologies
First Received: February 6, 2007   Last Updated: January 18, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lipodystrophy
HIV Infections
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
HIV-Associated Lipodystrophy Syndrome
Infection
More general conditions related to this trial
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Lipid Metabolism Disorders
Metabolic Diseases
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Skin Diseases
Skin Diseases, Metabolic
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
TH9507
Additional drug interventions recognized in this trial
Growth Hormone-Releasing Hormone
More general drug interventions related to this trial
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Theratechnologies


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services